Tokyo- And Bangkok-Based Opn, Formerly Synqa, A Digital Payments And Blockchain Tech Provider, Raises A $120M Series C+ At A $1B+ Valuation

XtalPi, a company that makes use of AI to aid in the discovery and development of drugs, raises $400 million in Series D funding that was led by OrbiMed and RRJ with a market value of $2 billion. – The company offers its AI technology to pharmaceutical companies in order to improve R&D for the development of new drugs. AI pharmaceutical company XtalPi has secured the sum of USD 400 million…

XtalPi, which makes use of AI to aid in drug discovery and development, increases 0M Series D, which is led by OrbiMed and RRJ, with a price of B (KrASIA).

tokyo bangkokbased synqa 120m series c